The most useful anxiety study in the cannabis literature used exactly two doses. University of Chicago researchers gave volunteers 7.5mg of THC before a standardized stress test and watched their anxiety drop below placebo. A second group got 12.5mg and their stress response climbed above it. Five milligrams separated the medicine from the problem, and both doses fit inside a single gummy from most brands.

That finding runs through every pick below. The dose decides whether cannabis treats anxiety or manufactures it, which is why this list leans CBD-forward and keeps THC content deliberately low. It also explains why we rebuilt the page around anxiety subtypes. A product that earns its place for generalized anxiety is a genuinely bad idea for panic disorder, and for three conditions in this cluster the honest recommendation is not a product at all.

Which anxiety are we talking about?

Generalized anxiety is the persistent, free-floating kind, and the subtype where low-dose cannabinoids have their best case. Social anxiety carries the strongest CBD trial evidence of the whole cluster. Panic disorder sits at the opposite end: THC's acute effects reproduce a panic attack's symptom checklist almost line for line, and our condition page treats it as close to a contraindication. Then there are the three where the market has run far ahead of the evidence: PTSD, comorbid depression, and seasonal affective disorder. Each gets a straight answer further down.

Find your subtype, read that section, ignore the rest.

Best for generalized anxiety

Camino Sparkling Pear CBD Gummies, 6mg CBD + 2mg THC ($18). The 3:1 ratio is the point. At 2mg, the THC stays well under the dose where the Chicago trial saw stress amplification, even if you take two, and the CBD buffers what little psychoactivity there is. This is the product we hand to people who are anxious about getting anxious from cannabis, because the formulation makes the bad outcome hard to reach. Clean pear flavor, Kiva's usual dosing consistency, and at $18 it is one of the few picks in this category priced like a consumable instead of a skincare line.

Wyld Huckleberry 1:1 Gummies, 5mg THC + 5mg CBD ($25). For people who have already established that moderate THC helps rather than hurts them. One gummy puts you near the trial's helpful dose with an equal CBD counterweight. Two puts you at 10mg THC, inside the zone where the curve bends the wrong way, so the serving discipline matters more here than with the Camino. Wyld earns the slot on execution: real fruit, findable batch COAs, and availability wide enough that you can rebuy the identical product, which is half of what makes any anxiety protocol work.

Best for social anxiety

Social anxiety is where CBD's evidence is strongest and where the retail market is most dishonest about doses. The landmark trial gave treatment-naive social anxiety patients 600mg of CBD before a simulated public speaking test and measured a real reduction in anxiety. Newer work points the same direction with a different schedule: four weeks of daily 300mg dosing improved social anxiety symptoms in a placebo-controlled trial of Japanese teenagers. Both numbers dwarf what any gummy contains. The practical translation, which our social anxiety page develops in full, is that sustained daily dosing beats swallowing something in the parking lot before the party.

Care By Design 8:1 CBD:THC Drops, 4mg CBD + 0.5mg THC per serving ($44). The daily-protocol pick. A tincture is the only affordable route to CBD doses that resemble the trial literature, and the dropper lets you titrate upward week by week instead of buying doses one gummy at a time. The trace THC supports the formulation without producing any experience you would notice at a dinner table.

Cann Social Tonic, 2mg THC + 4mg CBD per can ($20 per 6-pack). The event-night pick, recommended with its limits stated. At 2mg THC, a can takes an edge off without the dose overhead that spirals sensitive users, and holding a drink solves the what-do-I-do-with-my-hands problem that is half of party anxiety anyway. It is a well-designed low dose and a useful ritual. It is not a treatment, and Cann has never pretended otherwise, which we respect.

Best for panic disorder

Short section, on purpose. Racing heart, derealization, the conviction that something is medically wrong: THC at moderate doses produces the panic symptom list on demand, and emergency department data consistently puts edibles at the top of cannabis-related visits. Our panic disorder page walks through why this subtype gets a warning where the others get a protocol.

Dixie CBD Mints, 5mg CBD, zero THC ($16). The only product class we will put in front of a panic-prone reader is one with no THC in it. A pre-flight or pre-meeting mint is discreet, familiar, and carries a molecule with genuine anti-anxiety evidence behind it, at a dose far below where that evidence was generated. That gap is worth being honest about: for panic disorder, a 5mg mint is the ceiling of what a dispensary shelf responsibly offers, and the floor of what the research says works.

PTSD, depression, and winter: where we decline to rank

The largest meta-analysis of cannabinoid trials for mental health, covering 83 studies in Lancet Psychiatry, found scant evidence that cannabinoids improve any mental disorder, no qualifying controlled trials for depression at all, and no benefit for PTSD symptoms in the pooled randomized data. Cannabis is used for PTSD more than for almost anything else in the medical market. The gap between that usage and that evidence is the widest in cannabis medicine, and a product ranking that papers over it is doing sales, not editorial.

Seasonal affective disorder adds a pharmacology problem on top of the evidence problem. Winter depression already brings oversleeping and carbohydrate craving. THC is sedating and appetite-driving, which makes it directionally backwards for the condition it would claim to treat.

The defensible use in all three is second-order: treat the comorbid insomnia, pain, or generalized anxiety with the protocols on those pages, and watch whether mood follows. Our PTSD, comorbid depression, and seasonal affective disorder pages each map that logic, including the two narrow cases where an edible earns a place in a winter routine.

What we cut from the old list

The previous version of this page ranked a 10mg sativa gummy at number six for "experienced users." We have retired it. A double-strength THC product in an anxiety ranking asks the reader to gamble on being the exception to the dose curve this entire page is built on, and the readers most likely to take that gamble are the ones the curve punishes. It remains a fine product for other uses.

Also cut: the low-dose CBG blends. CBG's mood evidence is preclinical, so you would be paying gummy-brand prices for a molecule whose value to you rounds to zero, plus everything with "Calm" printed on a formulation identical to the brand's regular line. Renaming a gummy is not a clinical program.

Dosing when the ceiling is the danger

Start at 2.5mg THC or less, with equal or greater CBD, and hold one product steady for two weeks before judging it. The biphasic curve means "not working" is never an argument for doubling; move toward higher CBD ratios instead. And if you take psychiatric medication, have the interaction conversation with your prescriber before starting: CBD affects the liver enzymes that process several common SSRIs and benzodiazepines, and THC stacked on a benzodiazepine compounds sedation. The full protocol, with the trial-derived dose ranges, lives in our dosing guide and the condition pages linked throughout.

Cannabis is not a replacement for professional mental health treatment. If your anxiety is severe or worsening, talk to a healthcare provider. Some links on this page may be affiliate links.